---
title: "SILBERMAN DAVID — Ownership Dossier"
canonical: https://whiteintel.dev/entity/ca6a96e2-8baa-5fa9-b975-eea190c07fa8
json: https://whiteintel.dev/api/public/dossier/ca6a96e2-8baa-5fa9-b975-eea190c07fa8
identifier: sec:0001867998
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# SILBERMAN DAVID

**Type:** Company  
**Jurisdiction:** US  
**Identifier:** `sec:0001867998`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/ca6a96e2-8baa-5fa9-b975-eea190c07fa8  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/ca6a96e2-8baa-5fa9-b975-eea190c07fa8  

## Ownership & control

### Holdings / subsidiaries

- **COMPUGEN LTD** (officer) — https://whiteintel.dev/entity/caa8948e-355a-5dca-8f69-890defd64c55
- **NASUS PHARMA LTD** (director) — https://whiteintel.dev/entity/0ff4ba8b-bcbf-503a-b4ad-7080fa5bafdf
- **ORAMED PHARMACEUTICALS INC.** (officer) — https://whiteintel.dev/entity/88a43028-7c7b-5d93-b0bb-edce2492b7dc

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **SILBERMAN DAVID**. Human view: https://whiteintel.dev/entity/ca6a96e2-8baa-5fa9-b975-eea190c07fa8 · Structured JSON: https://whiteintel.dev/api/public/dossier/ca6a96e2-8baa-5fa9-b975-eea190c07fa8._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._